ARCT | Arcturus Therapeutics Holdings Inc
Category: Consumer goods
Quick infos Headquarters: California, United States Trade prices Volume: Market Cap: 426.93M Prev closed: Open: 20.68 High: 23.88 Low: 20.37 52 week low: 16.93 52 week high: 65 Dividends: No Dividends Next ER: May 9, 2023 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast May 9, 2023 1.87 / 0.0680.3M / 37.94MBeat! March 28, 2023 4.33 / 0.98160.29M / 72.68MBeat! February 27, 2023 - / 0.98- / 72.68MNovember 9, 2022 -1.33 / -1.8113.4M / 3.42MBeat! August 8, 2022 -0.82 / -1.9027.09M / 2.09MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 8, 2023 28.52 27.29 28.75
26.75
555K 5.24% May 5, 2023 27.1 27.09 27.17
26.27
425K 1.96% May 4, 2023 26.58 26.25 26.75
25.05
392K 0.38% May 3, 2023 26.48 25.44 26.76
25.29
425K 4.66% May 2, 2023 25.3 26.03 26.25
25.01
456K -3.14% May 1, 2023 26.12 26.57 26.58
25.35
461K -1.88% Apr 28, 2023 26.62 25.74 27.15
25.43
311K 2.66% Apr 27, 2023 25.93 26.91 27.58
25.88
308K -2.7% Apr 26, 2023 26.65 28.11 28.34
26.42
289K -5.09% Apr 25, 2023 28.08 28.46 28.79
27.95
390K -1.47% view more
NASDAQ - Nasdaq Stock Market
News
Arcturus Therapeutics up 21% after hours on quarterly beats, cash runway extension seekingalpha.com Mar 29, 2023 6:08 am Arcturus Therapeutics EPS of $4.33, revenue of $160.29M beats by $79.77M seekingalpha.com Mar 29, 2023 4:02 am
Arcturus Therapeutics (ARCT) Beats Q4 Earnings and Revenue Estimates finance.yahoo.com Mar 28, 2023 5:15 pm Arcturus Therapeutics Q4 2022 Earnings Preview seekingalpha.com Mar 28, 2023 5:35 am
Market Sentiment Around Loss-Making Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) finance.yahoo.com Mar 27, 2023 9:11 am
Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023 finance.yahoo.com Mar 7, 2023 8:00 am
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis finance.yahoo.com Jan 31, 2023 8:30 am
CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology finance.yahoo.com Jan 4, 2023 6:00 pm
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress finance.yahoo.com Jan 4, 2023 4:01 pm
Arcturus Reports Durability Data Against Omicron Variants, Including BA.5, at Six-Month Timepoint Following Booster with ARCT-154 COVID-19 Vaccine finance.yahoo.com Jan 4, 2023 8:00 am
Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com Dec 19, 2022 8:30 am
CSL Announces Closing of Global Collaboration and Licensing Agreement with Arcturus Therapeutics finance.yahoo.com Dec 12, 2022 8:30 am
These Analysts Just Made A Significant Downgrade To Their Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) EPS Forecasts finance.yahoo.com Nov 16, 2022 5:24 am Arcturus downgraded at Baird on delayed catalyst and uncertainties in CSL deal seekingalpha.com Nov 11, 2022 3:21 am Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44, revenue of $13.4M beats by $9.31M seekingalpha.com Nov 10, 2022 5:03 am Arcturus Therapeutics Q3 2022 Earnings Preview seekingalpha.com Nov 9, 2022 6:35 am Arcturus' mRNA therapy for cystic fibrosis cleared for early-stage trial in New Zealand seekingalpha.com Jan 31, 2023 10:14 pm
Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines finance.yahoo.com Jan 4, 2023 7:43 am
Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study finance.yahoo.com Jan 4, 2023 7:30 am
Swelling losses haven't held back gains for Arcturus Therapeutics Holdings (NASDAQ:ARCT) shareholders since they're up 109% over 5 years finance.yahoo.com Dec 28, 2022 11:35 am This company doesn't provide a dividend.
Key Persons CEO : Joseph E. Payne (31 May 2018–) CFO : Andrew H. Sassine Talk about Arcturus Therapeutics Holdings Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
arcturustherapeuticsinc.gcs-web.com If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?